TAU Intervention
sleep disorders, OCD
The TAU group was treated with only medication. The medication interventions of the 3 groups were under the charge of an associate chief psychiatrist, who was unaware of the grouping of patients. The medicines used for the treatment of OCD in this study were SSRIs approved by the State Food and Drug Administration (SFDA). The medication treatment lasted for 6 weeks. Patients with sleep disorders could use benzodiazepines in combination, but benzodiazepines should not be taken continuously for more than 2 weeks, and other psychotropic medicines were not used in combination. The medicines used in this study were commonly used in the clinic, which had good safety and fewer side effects. The evaluations of patients’ side effects and adverse information by an outpatient doctor were collected regularly. If patients failed to comply with the agreement and stopped the medicines by themselves, they were deemed to have withdrawn from the study.